Glucocorticoid withdrawal in polymyalgia rheumatica: the theory versus the practice M. Yates, R.A. Watts, F. Swords, A.J. Macgregor
One year in review
CER10177 2017,35,1 Pg. 0003-0017
Free to view
One year in review 2016: spondyloarthritis A. Parma, L. Cometi, M.C. Leone, G. Lepri, R. Talarico, S. Guiducci
Full Papers
CER9100 2017,35,1 Pg. 0018-0023
Free to view
Serum complement C3 strongly correlates with whole-body insulin sensitivity in rheumatoid arthritis F. Ursini, S. D'angelo, E. Russo, F. Arturi, L. D'antona, C. Bruno, S. Naty, G. De Sarro, I. Olivieri, R.D. Grembiale
CER8943 2017,35,1 Pg. 0024-0032
Free to view
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE) F. Ceccarelli, U. Massafra, C. Perricone, L. Idolazzi, R. Giacomelli, R. Tirri, R. Russo, G. Pistone, P. Ruscitti, S. Parisi, P.P. Sainaghi, F. Cacciapaglia, A. Zullo, V. Marino, A. Migliore, G. Valesini
CER9125 2017,35,1 Pg. 0033-0042
Free to view
Molecular markers of systemic autoimmune disorders: the expression of MHC-located HSP70 genes is significantly associated with autoimmunity development M. Mišunová, T. Svitálková, L. Pleštilová, O. Kryštufková, D. Tegzová, R. Svobodová, M. Hušáková, M. Tomčík, R. Bečvář, J. Závada, H. Mann, L. Kolesár, A. Slavčev, J. Vencovský, P. Novota
CER9147 2017,35,1 Pg. 0043-0052
Free to view
Evolution of imaging findings, laboratory and functional parameters in rheumatoid arthritis patients after one year of treatment with anti-TNF-α agents
E.E. Detorakis, E. Magkanas, I. Lasithiotaki, P. Sidiropoulos, D.T. Boumpas, N. Gourtsoyiannis, K. Antoniou, M. Raissaki
CER9388 2017,35,1 Pg. 0053-0060
Free to view
The infrapatellar fat pad induces inflammatory and degradative effects in articular cells but not through leptin or adiponectin J.-B. Gross, C. Guillaume, P. Gegout-Pottie, P. Reboul, J.-Y. Jouzeau, D. Mainard, N. Presle
CER9453 2017,35,1 Pg. 0061-0068
Free to view
Long-term drug survival and clinical effectiveness of etanercept treatment in patients with ankylosing spondylitis in daily clinical practice S. Arends, E. Brouwer, M. Efde, E. Van Der Veer, H. Bootsma, F. Wink, A. Spoorenberg
CER9483 2017,35,1 Pg. 0069-0073
Free to view
The Schnitzler syndrome: chronic urticaria in disguise: a single-centre report of 11 cases and a critical reappraisal of the literature.
S. Vanderschueren, A. Van Der Veen
CER9420 2017,35,1 Pg. 0074-0079
Free to view
Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission J. Ramírez, J. Inciarte-Mundo, A. Cuervo, V. Ruiz-Esquide, M.V. Hernández, R. Sanmartí, J.D. Cañete
CER9395 2017,35,1 Pg. 0080-0084
Free to view
Clinical features and management of erythromelalgia: long term follow-up of 46 cases L.K. Parker, C. Ponte, K.J. Howell, V.H. Ong, C.P. Denton, B.E. Schreiber
CER9354 2017,35,1 Pg. 0085-0092
Free to view
Improvement of fatigue in patients with rheumatoid arthritis treated with biologics: relationship with sleep disorders, depression and clinical efficacy. A prospective, multicentre study M. Genty, B. Combe, M. Kostine, E. Ardouin, J. Morel, C. Lukas
CER9400 2017,35,1 Pg. 0093-0097
Free to view
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: an observational multicentre study C. Giannitti, G. Lopalco, A. Vitale, D. Rigante, M.G. Anelli, M. Fabbroni, S. Manganelli, M. Galeazzi, B. Frediani, M. Barone, G. Lapadula, F. Iannone, L. Cantarini
CER9410 2017,35,1 Pg. 0098-0107
Free to view
Sjögren's syndrome: managed care data from a large United States population highlight real-world health care burden and lack of treatment options J.A. Birt, Y. Tan, N. Mozaffarian
CER9458 2017,35,1 Pg. 0108-0112
Free to view
Low levels of calcium or vitamin D - which is more important in systemic lupus erythematosus patients? An extensive data analysis
A. Watad, S. Tiosano, S. Azrielant, A. Whitby, D. Comaneshter, A.D. Cohen, Y. Shoenfeld, H. Amital
CER9484 2017,35,1 Pg. 0113-0121
Free to view
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis G. Ciancio, M. Ferracin, E. Saccenti, V. Bagnari, I. Farina, F. Furini, E. Galuppi, B. Zagatti, F. Trotta, M. Negrini, M. Govoni
CER9544 2017,35,1 Pg. 0122-0128
Free to view
Factors associated with the decision of the rheumatologist to order sacroiliac joints magnetic resonance imaging (SI-MRI) or HLA-B27 testing in the diagnostic work-up of patients with spondyloarthritis in clinical practice W. Bautista-Molano, R.B. Landewé, C. Serna, R. Valle-Oñate, D. Van Der Heijde
CER9551 2017,35,1 Pg. 0129-0136
Free to view
Phagocyte-specific S100A8/A9 is upregulated in primary Sjögren’s syndrome and triggers the secretion of pro-inflammatory cytokines in vitro
C. Nicaise, L. Weichselbaum, L. Schandene, V. Gangji, F. Dehavay, J. Bouchat, B. Balau, T. Vogl, M.S. Soyfoo
Brief Papers
CER9281 2017,35,1 Pg. 0137-0140
Free to view
Paradoxical onset of psoriatic arthritis during treatment with biologic agents for plaque psoriasis: a combined dermatology and rheumatology clinical study. M. Napolitano, N. Balato, F. Caso, L. Costa, M. Megna, T. Cirillo, A. Balato, R. Scarpa
CER9174 2017,35,1 Pg. 0141-0144
Free to view
Limited association between scalp psoriasis and psoriatic arthritis severity and treatment response K. De Vlam, L. Mallbris, A. Szumski, H. Jones
CER9425 2017,35,1 Pg. 0145-0148
Free to view
Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis J. Rosas, F. Llinares-Tello, J.M. Senabre-Gallego, X. Barber-Vallés, G. Santos-Soler, E. Salas-Heredia, A. Pons Bas, C. Cano Pérez, M. García-Carrasco and the AIRE-MB Group
Case Reports
CER9831 2017,35,1 Pg. 0149-0151
Free to view
Fulminant bilateral papilloedema during low-dose steroid taper in a child with systemic idiopathic arthritis treated with tocilizumab L. Burstzyn, S. Levin, B. Rotenberg, T. Van Hooren, A. Leung, R. Berard, D.S. Ardelean
Review
CER9440 2017,35,1 Pg. 0152-0160
Free to view
Efficacy and safety of down-titration versus continuation strategies of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis with low disease activity or in remission: a systematic review and meta-analysis M. Jiang, F. Ren, Y. Zheng, R. Yan, W. Huang, N. Xia, L. Luo, J. Zhou, L. Tang
Paediatric Rheumatology
CER9714 2017,35,1 Pg. 0161-0168
Free to view
Excellent balance skills despite active and inactive juvenile idiopathic arthritis – unexpected results of a cross-sectional study
J. Merker, M. Hartmann, F. Kreuzpointner, A. Schwirtz, J.-P. Haas
Letters to the Editor
CER9611 2017,35,1 Pg. 0169
Free to view
Clinical effects of mud-bath therapy and oral glucosamine sulfate after 6 months of discontinuation in patients with knee osteoarthritis: results from a randomised, controlled, crossover study. F. Caso, L. Costa, A. Del Puente, D. Sorbo, U. Balestrieri, R. Peluso, R. Scarpa
CER9212 2017,35,1 Pg. 0170-0171
Free to view
Long-term tocilizumab efficacy in a patient with psoriatic arthritis and AA amyloidosis L. Dinoia, G. Lopalco, L. Cantarini, L. Gesualdo, M. Rossini, F. Iannone
CER9369 2017,35,1 Pg. 0171
Free to view
Reply to: Long-term tocilizumab efficacy in a patient with psoriatic arthritis and AA amyloidosis. Dinoia et al. T. Lane, H.J. Lachmann
CER9545 2017,35,1 Pg. 0172
Free to view
Severe thrombocytopenic purpura after meningococcal C vaccination in a woman affected by systemic lupus erythematosus F. Angelotti, A. Tavoni
CER9184 2017,35,1 Pg. 0173
Free to view
Can speckle tracking echocardiography detect subclinical left ventricular dysfunction in patients with primary Sjögren’s syndrome? F. Atzeni, L. Gianturco, C. Colombo, C. Ricci, P. Sarzi-Puttini, M. Turiel
CER9780 2017,35,1 Pg. 0174
Free to view
Subcutaneous panniculitis-like T-cell lymphoma with haemophagocytic syndrome during tocilizumab therapy for juvenile idiopathic arthritis H. Nakamura, T. Sugai, M. Kato, K.C. Hatanaka, T. Atsumi
CER9762 2017,35,1 Pg. 0175
Free to view
Abortion of the UVEXATE study: are we unable to evaluate cheap and well-tolerated treatments? F. Rodrigues, E. Vicaut, S. Abad
CER9330 2017,35,1 Pg. 0176-0177
Free to view
Autoantibody testing in patients with myositis: clinical accuracy of a multiparametric line immunoassay A. Ghirardello, S. Bettio, N. Bassi, M. Gatto, M. Beggio, I. Lundberg, G. Vattemi, L. Iaccarino, L. Punzi, A. Doria
Erratum Corrige
CER10279 2017,35,1 Pg. 0177
Free to view
Development of pristane induced mice model for lupus withatherosclerosis and analysis of TLR expression X. Chen, R. Cui, R. Li, H. Lin, Z. Huang, L. Lin